Expected cumulative effects and costs of universal vaccination of persons aged 60 years with 23-valent pneumococcal polysaccharide vaccine (PPV23), ten years after program implementation in Brazil.

1 Current practice: vaccination of institutionalized elderly and elderly with underlying diseases2 The number of deaths included deaths from invasive pneumococcal disease (IPD) and from all-cause pneumonia. The number of deaths prevented refers to the impact of the vaccine on IPD and all-cause pneumonia.3 In United States Dollars (USD$) as of December 2011.4 Intervention cost includes the cost of one vaccine dose (USD$6.25), administration costs (USD$1.90 per dose) and 5% wastage of vaccine (USD$0.31)Expected cumulative effects and costs of universal vaccination of persons aged 60 years with 23-valent pneumococcal polysaccharide vaccine (PPV23), ten years after program implementation in Brazil.